Skip to main content
Premium Trial:

Request an Annual Quote

Carl Hull, Gregory Schiffman

Premium
Carl Hull, formerly vice president and general manager of Applied Biosystems’ Sequence Detection System and Microarray business units, has joined Gen-Probe as executive vice president and COO.
 
Prior to ABI, Hull was CEO at Applied Imaging and he worked in marketing and sales at Ventana Medical Systems and at Abbott Laboratories.
 

 

Former Affymetrix CFO Gregory Schiffman has joined the board of directors of Entelos. Schiffman is CFO at Dendreon. He also was a vice president and controller for Applied Biosystems and a manager at Hewlett Packard and at IBM.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.